Torrent Pharmaceuticals Limited has received FDA approval for its ANDA for Lurasidone Hydrochloride Oral, supporting the firm's broadening generic pharmaceutical portfolio. This entry aims to strengthen market positioning by providing affordable access to this popular antipsychotic, intensifying competition in the relevant branded and generic segments.